Key facts
- CARI Health’s last known valuation is $5.0M (Jul 2023).
- It has raised $3.5M across 2 recorded rounds; the latest was Seed Round ($2.3M) in May 2022.
- Notable investors include US National Science Foundation, MedTech Innovator, National Institutes of Health, CONNECT (San Diego), Matter (Consulting Services (B2B)) — 16 tracked in total.
- CARI Health has filed 4 Form Ds with the SEC since 2022, most recently Jul 2025 ($100K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for CARI Health
Funding rounds
2 roundsAbout CARI Health
Operator of a sensor-enabled digital health company intended to develop remote medication monitoring solutions to inform personalized dosing. The company offers a wearable remote medication monitor that consists of wireless sensors that are worn on the patient's skin and send data about real-time medication levels to the cloud, enabling clinicians to safely dose and titrate life-saving medications with a narrow therapeutic window.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2015
- Employees
- 6
- Website
- carihealth.com/
- Ownership
- Privately Held (backing)
CARI Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CARI Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CARI Health in its N-PORT filings yet. We sweep new filings monthly.